BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brito VGB, Patrocinio MS, de Sousa MCL, Barreto AEA, Frasnelli SCT, Lara VS, Santos CF, Oliveira SHP. Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease. Front Pharmacol 2020;11:579926. [PMID: 33364953 DOI: 10.3389/fphar.2020.579926] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Hersh EV, Wolff M, Moore PA, Theken KN, Daniell H. A Pair of "ACEs". J Dent Res 2022;101:5-10. [PMID: 34689655 DOI: 10.1177/00220345211047510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
2 Kutlu Z, Bilen A, Celik M, Maman A, Gulaboglu M, Kul A, Celik Z, Halici Z. The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats. J Pharm Pharmacol 2021;73:1693-702. [PMID: 34874446 DOI: 10.1093/jpp/rgab123] [Reference Citation Analysis]
3 Balera Brito VG, Patrocinio MS, Alves Barreto AE, Tfaile Frasnelli SC, Lara VS, Santos CF, Penha Oliveira SH. Telmisartan impairs the in vitro osteogenic differentiation of mesenchymal stromal cells from spontaneously hypertensive male rats. Eur J Pharmacol 2021;912:174609. [PMID: 34743978 DOI: 10.1016/j.ejphar.2021.174609] [Reference Citation Analysis]
4 Lima MLS, Martins AA, Medeiros CACX, Guerra GCB, Santos R, Bader M, Pirih FQ, Araújo Júnior RF, Brito GAC, Leitão RFC, Silva RA, Barbosa SJA, Melo RCO, Araújo AA. The Receptor AT1 Appears to Be Important for the Maintenance of Bone Mass and AT2 Receptor Function in Periodontal Bone Loss Appears to Be Regulated by AT1 Receptor. Int J Mol Sci 2021;22:12849. [PMID: 34884653 DOI: 10.3390/ijms222312849] [Reference Citation Analysis]